Review: taking Magnesium glycinate and Plavix together


Summary

Drug interactions are reported among people who take Magnesium glycinate and Plavix together. This review analyzes the effectiveness and drug interactions between Magnesium glycinate and Plavix. It is created by eHealthMe based on reports of 1,199 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Magnesium Glycinate

Magnesium glycinate has active ingredients of magnesium. It is often used in supplementation therapy. (latest outcomes from Magnesium glycinate 80 users)

Plavix

Plavix has active ingredients of clopidogrel bisulfate. It is often used in stent. (latest outcomes from Plavix 101,521 users)

On Sep, 18, 2016

1,199 people who take Magnesium Glycinate, Plavix are studied.


Number of reports submitted per year:

Magnesium glycinate and Plavix drug interactions.

Drug effectiveness over time:

Magnesium Glycinate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 3 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 33.0% - (1 of 3 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Plavix:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 100.0% - (2 of 2 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Magnesium Glycinate:
  • female: 60.0% - (3 of 5 people)
  • male: 0.0% - (0 of 3 people)
Plavix:
  • female: 100.0% - (5 of 5 people)
  • male: 0.0% - (0 of 3 people)

Drug effectiveness by age:

Magnesium Glycinate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 40.0% - (2 of 5 people)
Plavix:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 80.0% - (4 of 5 people)

Most common drug interactions over time *:

< 1 month:
  • renal failure
  • cardiac failure
  • renal impairment
  • multi-organ failure
  • renal failure acute
  • hepatic failure
  • pneumonia
  • pyrexia
  • pain
  • ventricular tachycardia
1 - 6 months:
  • pyrexia
  • urinary tract infection
  • anastomotic leak
  • atrial fibrillation
  • cerebral infarction
  • decreased appetite
  • dehydration
  • female genital tract fistula
  • hypoalbuminaemia
  • hypokalaemia
6 - 12 months:
  • somnambulism
  • gastric cancer
  • death
  • gastrointestinal haemorrhage
  • large intestine carcinoma
  • coronary artery stenosis
  • pneumonia
  • arteriosclerosis obliterans
  • cellulitis
  • diabetic gangrene
1 - 2 years:
  • dyspnoea
  • fatigue
  • death
  • atrial fibrillation
  • asthenia
  • coronary artery occlusion
  • diverticulitis
  • fibromyalgia
  • gastritis
  • gastritis erosive
2 - 5 years:
  • gastrointestinal haemorrhage
  • pleural effusion
  • post procedural complication
  • abdominal abscess
  • abdominal pain upper
  • adrenal mass
  • diarrhoea
  • drug ineffective
  • enterocutaneous fistula
  • general physical health deterioration
5 - 10 years:
  • diarrhoea
  • electrolyte imbalance
  • fall
  • gastroenteritis viral
  • adverse event
  • asthma
  • blood potassium decreased
  • bronchitis
  • cardiac disorder
  • choking
10+ years:
  • gastrointestinal haemorrhage
  • haemoglobin decreased
  • skin rash
  • ulcer haemorrhage
not specified:
  • pain
  • dyspnoea
  • fatigue
  • anxiety
  • cardiac failure congestive
  • asthenia
  • anaemia
  • nausea
  • atrial fibrillation
  • fall

Most common drug interactions by gender *:

female:
  • nausea
  • pain
  • dyspnoea
  • fatigue
  • fall
  • asthenia
  • diarrhoea
  • dizziness
  • pain in extremity
  • hypotension
male:
  • pain
  • cardiac failure congestive
  • dyspnoea
  • pneumonia
  • anxiety
  • anaemia
  • atrial fibrillation
  • coronary artery disease
  • oedema peripheral
  • fatigue

Most common drug interactions by age *:

10-19:
  • cardiac fibrillation
  • adverse event
  • blood cholesterol increased
  • body height decreased
  • cardiovascular disorder
  • chronic obstructive pulmonary disease
  • dyspepsia
  • dysphagia
  • dyspnoea
  • gait disturbance
20-29:
  • abdominal pain upper
  • abscess
  • alcoholic liver disease
  • anaemia
  • aneurysm
  • anxiety
  • arrhythmia
  • arterial stenosis
  • arthralgia
  • arthropathy
30-39:
  • fall
  • muscle strain
  • adverse event
  • asthma
  • blood potassium decreased
  • bronchitis
  • cardiac disorder
  • choking
  • diarrhoea
  • dyspnoea
40-49:
  • anxiety
  • torsade de pointes
  • ventricular fibrillation
  • diarrhoea
  • pain
  • apathy
  • coronary artery occlusion
  • depression
  • emotional distress
  • fatigue
50-59:
  • pain
  • oedema peripheral
  • pneumonia
  • anxiety
  • cardiac failure congestive
  • coronary artery disease
  • dyspnoea
  • erythema
  • nausea
  • hypotension
60+:
  • dyspnoea
  • pain
  • asthenia
  • fall
  • fatigue
  • anaemia
  • anxiety
  • nausea
  • atrial fibrillation
  • cardiac failure congestive

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Magnesium glycinate and Plavix?

Can you answer these questions?

More questions for: Magnesium glycinate, Plavix

You may be interested in these reviews

More reviews for: Magnesium glycinate, Plavix

On eHealthMe, Magnesium glycinate (magnesium) is often used to treat supplementation therapy. Plavix (clopidogrel bisulfate) is often used to treat stent. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.